[HTML] lww.com

[HTML][HTML] Implant based breast reconstruction with acellular dermal matrix: safety data from an open-label, multicenter, randomized, controlled trial in the setting of …

F Lohmander, J Lagergren, PG Roy, H Johansson… - 2019 - journals.lww.com
Objective: To evaluate clinical outcomes of using acellular dermal matrix (ADM) with implant
based breast reconstructions (IBBRs) in a randomized controlled trial. Summary Background …
被引用次数：65 相关文章

Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast …

F Lohmander, J Lagergren, PG Roy, H Johansson… - 2019 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate clinical outcomes of using acellular dermal matrix (ADM) with implant
based breast reconstructions (IBBRs) in a randomized controlled trial. Summary background …

Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast …

F Lohmander, J Lagergren, PG Roy… - Annals of …, 2019 - europepmc.org
Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an
Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment …
[HTML] lww.com

[HTML][HTML] Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting …

F Lohmander, J Lagergren, PG Roy, H Johansson… - 2019 - journals.lww.com
Objective: To evaluate clinical outcomes of using acellular dermal matrix (ADM) with implant
based breast reconstructions (IBBRs) in a randomized controlled trial. Summary Background …